AZTA Logo

Azenta, Inc. (AZTA) 

NASDAQ
Market Cap
$2.29B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
458 of 776
Rank in Industry
31 of 48

Largest Insider Buys in Sector

AZTA Stock Price History Chart

AZTA Stock Performance

About Azenta, Inc.

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their …

Insider Activity of Azenta, Inc.

Over the last 12 months, insiders at Azenta, Inc. have bought $0 and sold $69,670 worth of Azenta, Inc. stock.

On average, over the past 5 years, insiders at Azenta, Inc. have bought $752,191 and sold $13.79M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 8,625 shares for transaction amount of $501,544 was made by McManus Matthew (EVP & Chief Operating Officer) on 2022‑08‑19.

List of Insider Buy and Sell Transactions, Azenta, Inc.

2024-10-17SaleEVP, Chief Financial Officer
1,595
0.0033%
$43.68$69,670-3.22%
2023-08-11SaleChief Strategy & New Business
10,877
0.0166%
$56.03$609,438-0.58%
2023-08-10SaleChief Strategy & New Business
10,732
0.017%
$57.24$614,300+0.32%
2023-06-06Saledirector
2,400
0.0033%
$43.07$103,368+19.66%
2022-08-19PurchaseEVP & Chief Financial Officer
4,350
0.0058%
$57.62$250,647-20.56%
2022-08-19PurchaseEVP & Chief Operating Officer
8,625
0.0116%
$58.15$501,544-20.56%
2022-04-12SaleSVP, Chief HR Officer
132
0.0002%
$78.02$10,299-25.53%
2022-01-04SaleChief Commercial Officer, LS
191
0.0003%
$102.59$19,595-32.86%
2021-11-19SalePresident, Semi Solutions
10,216
0.0138%
$120.29$1.23M-37.27%
2021-11-18SaleChief Strategy & New Business
4,049
0.0054%
$118.48$479,726-37.28%
2021-11-18SaleSVP, GM BLS-Products
6,490
0.0087%
$119.03$772,505-37.28%
2021-11-17SaleCEO
41,351
0.0553%
$119.27$4.93M-37.25%
2021-11-17SaleEVP & Chief Financial Officer
18,331
0.0245%
$119.27$2.19M-37.25%
2021-11-17SaleSVP, General Counsel, Secy.
8,694
0.0116%
$119.27$1.04M-37.25%
2021-11-17SaleChief Strategy & New Business
7,402
0.0099%
$119.27$882,837-37.25%
2021-11-17SalePresident, Semi Solutions
13,100
0.0175%
$119.27$1.56M-37.25%
2021-11-17SaleSVP, GM BLS-Products
8,878
0.0119%
$119.27$1.06M-37.25%
2021-11-17SalePrincipal Accounting Officer
4,830
0.0065%
$119.27$576,074-37.25%
2021-11-12Saledirector
2,831
0.0038%
$114.13$323,102-34.55%
2021-09-27SaleSVP, Human Resources
4,140
0.0056%
$110.00$455,400-25.92%

Insider Historical Profitability

13.89%
Robertson Lindon GEVP & Chief Financial Officer
100571
0.2056%
$46.77220+14.96%
ALLEN A CLINTONdirector
69093
0.1412%
$46.7710+46.23%
McManus MatthewEVP & Chief Operating Officer
29467
0.0602%
$46.7710<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$322.53M9.925.35M-5.3%-$18.05M0.01
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$313.29M9.645.2M+12.41%+$34.59M0.73
BlackRock$306.37M9.435.08M-6.97%-$22.94M0.01
Politan Capital Management Lp$278M8.554.61M+0.74%+$2.03M14.46
Dimensional Fund Advisors$153.67M4.732.55M+14.22%+$19.14M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.